Research Center for Endocrine and Metabolic Diseases, Chungnam National University College of Medicine, Daejeon, Korea.
Endocrinol Metab (Seoul). 2019 Mar;34(1):39-46. doi: 10.3803/EnM.2019.34.1.39.
The signaling network of the mitochondrial unfolded protein response (UPR) and mitohormesis is a retrograde signaling pathway through which mitochondria-to-nucleus communication occurs in organisms. Recently, it has been shown that the UPR is closely associated with metabolic disorders and conditions involving insulin resistance, such as alcoholic and non-alcoholic fatty liver and fibrotic liver disease. Scientific efforts to understand the UPR and mitohormesis, as well as to establish the mitochondrial proteome, have established the importance of mitochondrial quality control in the development and progression of metabolic liver diseases, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). In this review, we integrate and discuss the recent data from the literature on the UPR and mitohormesis in metabolic liver diseases, including NAFLD/NASH and fibrosis.
线粒体未折叠蛋白反应 (UPR) 和线粒体应激的信号网络是一种逆行信号通路,通过该通路,线粒体与细胞核之间发生生物体内的通讯。最近,已经表明 UPR 与代谢紊乱和涉及胰岛素抵抗的疾病密切相关,如酒精性和非酒精性脂肪肝以及纤维化性肝病。为了理解 UPR 和线粒体应激,以及建立线粒体蛋白质组,科学界进行了努力,这确立了线粒体质量控制在代谢性肝病(包括非酒精性脂肪性肝病 (NAFLD) 和非酒精性脂肪性肝炎 (NASH))的发展和进展中的重要性。在这篇综述中,我们整合并讨论了文献中关于代谢性肝病(包括 NAFLD/NASH 和纤维化)中 UPR 和线粒体应激的最新数据。